Cargando…
Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TPM1 variant S215L
Hypertrophic cardiomyopathy (HCM) is an inherited disorder often caused by mutations to sarcomeric genes. Many different HCM-associated TPM1 mutations have been identified but they vary in their degrees of severity, prevalence, and rate of disease progression. The pathogenicity of many TPM1 variants...
Autores principales: | Halder, Saiti S, Rynkiewicz, Michael J, Creso, Jenette G, Sewanan, Lorenzo R, Howland, Lindsey, Moore, Jeffrey R, Lehman, William, Campbell, Stuart G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991458/ https://www.ncbi.nlm.nih.gov/pubmed/36896133 http://dx.doi.org/10.1093/pnasnexus/pgad011 |
Ejemplares similares
-
Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation
por: Sewanan, Lorenzo R., et al.
Publicado: (2021) -
Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue
por: Shen, Shi, et al.
Publicado: (2022) -
Predicting Effects of Tropomyosin Mutations on Cardiac Muscle Contraction through Myofilament Modeling
por: Sewanan, Lorenzo R., et al.
Publicado: (2016) -
Prospects for remodeling the hypertrophic heart with myosin modulators
por: Sewanan, Lorenzo R., et al.
Publicado: (2022) -
Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes
por: Sewanan, Lorenzo R., et al.
Publicado: (2019)